	title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	treatment_protocol_ch1	growth_protocol_ch1	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	source_name_ch2	organism_ch2	characteristics_ch2	characteristics_ch2	characteristics_ch2	characteristics_ch2	treatment_protocol_ch2	growth_protocol_ch2	molecule_ch2	extract_protocol_ch2	label_ch2	label_protocol_ch2	taxid_ch2	hyb_protocol	scan_protocol	description	description	data_processing	data_processing	platform_id	contact_name	contact_email	contact_phone	contact_fax	contact_laboratory	contact_department	contact_institute	contact_address	contact_city	contact_zip/postal_code	contact_country	supplementary_file	data_row_count
GSM556649	R1881-treated LNCaP versus control LNCaP, rep1	GSM556649	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	R1881-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate AB1.	AB_17607	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556649/GSM556649.gpr.gz	27648
GSM556650	R1881-treated LNCaP versus control LNCaP, rep2	GSM556650	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	R1881-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate AB2.	AB_41067	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556650/GSM556650.gpr.gz	27648
GSM556651	control LNCaP versus R1881-treated LNCaP, rep1	GSM556651	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	R1881-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BA1.	BA_17609	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556651/GSM556651.gpr.gz	27648
GSM556652	control LNCaP versus R1881-treated LNCaP, rep2	GSM556652	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	R1881-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BA2.	BA_41068	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556652/GSM556652.gpr.gz	27648
GSM556653	CHX/R1881-treated LNCaP versus control LNCaP, rep1	GSM556653	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate CB1.	CB_17608	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556653/GSM556653.gpr.gz	27648
GSM556654	CHX/R1881-treated LNCaP versus control LNCaP, rep2	GSM556654	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate CB2.	CB_41069	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556654/GSM556654.gpr.gz	27648
GSM556655	control LNCaP versus CHX/R1881-treated LNCaP, rep1	GSM556655	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BC1.	BC_17610	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556655/GSM556655.gpr.gz	27648
GSM556656	control LNCaP versus CHX/R1881-treated LNCaP, rep2	GSM556656	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BC2.	BC_41071	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556656/GSM556656.gpr.gz	27648
GSM556657	CHX-treated LNCaP versus control LNCaP, rep1	GSM556657	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate DB1.	DB_17741	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556657/GSM556657.gpr.gz	27648
GSM556658	CHX-treated LNCaP versus control LNCaP, rep2	GSM556658	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate DB2.	DB_41155	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556658/GSM556658.gpr.gz	27648
GSM556659	control LNCaP versus CHX-treated LNCaP, rep1	GSM556659	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BD1.	BD_17602	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556659/GSM556659.gpr.gz	27648
GSM556660	control LNCaP versus CHX-treated LNCaP, rep2	GSM556660	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	control non-stimulated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h	sample type: control	LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate BD2.	BD_41156	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556660/GSM556660.gpr.gz	27648
GSM556661	CHX/R1881-treated LNCaP versus CHX-treated LNCaP	GSM556661	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate CD1.	CD_17604	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556661/GSM556661.gpr.gz	27648
GSM556662	CHX-treated LNCaP versus CHX/R1881-treated LNCaP	GSM556662	Public on Jun 14 2014	Jun 15 2010	Jun 14 2014	RNA	2	CHX-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy3	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	CHX/R188-treated LNCaP	Homo sapiens	cell line: LNCaP	cell type: prostatic tumoral cells	treatment: steroid-depleted for 48h and treated with 25µgml CHX and 1nM R1881 for 24h		LNCaP cells were then treated with 1 nM R1881 and/or 25 µg/ml of cycloheximide for 24 h. When cycloheximide treatment was combined with androgen stimulation, cycloheximide was added into the medium simultaneously with R1881.	5x10^5 LNCaP cells were plated onto 25 cm2 flasks in RPMI-1640 complete medium for 36 h and steroid-deprived by culturing for 48 h in phenol red-free RPMI-1640 medium supplemented with 5% dextran-coated charcoal-stripped FBS.	total RNA	Total RNA were extracted using the Rneasy mini kit (Qiagen) following manufacturer's instructions.	Cy5	1 µg of total RNA was amplified with the Amino Allyl MessageAmp II aRNA amplification kit (1752, Ambion) according to the manufacturer’s instructions. Fluorescent probes were synthesized by chemical coupling of 5 µg of aminoallyl aRNA with cyanine Cy3 or Cy5 dyes. Fluorescent probes were purified using Rneasy mini kit (Qiagen).	9606	1 µg of combined Cy3/Cy5 dye-labeled aRNA were hybridized competitively to microarray slides for 18 h at 62°C in hybridization buffer (5185-5973, Agilent) and under Agilent Gasket slide coverslip (Agilent hybridization chamber, G2534A, Agilent) in a rotative Agilent hybridization oven. Several post-hybridization washes were performed.	Fluorescent microarray TIFF images were collected for both Cy3 and Cy5 by scanning washed and dried glass slides with a GenePix 4000B microarray scanner (Axon Instruments).	Biological replicate DC1.	DC_17603	Image intensity data were extracted and analysed with GenePixPro6.0 microarray analysis software. After visual inspection, spots of insufficient quality were flagged and excluded from further analysis. GenePix data files (gpr format) were then generated.	Signal intensities were log2-transformed (Cy3/Cy5) and normalization was performed by the intensity-dependent Lowess method. Data were imported and analyzed into the R Bioconductor software in order to identify genes with potentially significant change in expression in response to R1881/CHX treatment.	GPL1456	Nathalie,,ALLIOLI	Nathalie.Allioli@recherche.univ-lyon1.fr	33(0)426235934	33(0)426235900	équipe Oncogenèse et Développement	Institut de Génomique Fonctionnelle de Lyon (IGFL) 	Ecole Normale Supérieure de Lyon (ENS)	46 Allée d'Italie	Lyon Cedex 07	69364	France	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM556nnn/GSM556662/GSM556662.gpr.gz	27648
